文献速递重症综合管理与镇静镇痛心脑血管急症复苏、休克与脓毒症

澳大利亚和新西兰ICU过去30年关键诊断组死亡率趋势

Mortality Trends Across Key Diagnostic Groups in Australian and New Zealand ICUs Over the Past 30 Years.
PubMed 文献 · Crit Care Med · 2025-08-14
一句话结论过去30年澳大利亚和新西兰ICU风险校正死亡率显著改善,但2010年后趋于平台,心脏骤停死亡率近10年似有上升。

该研究为回顾性队列研究,纳入1993年1月至2022年12月澳大利亚和新西兰209个ICU的2,838,654例成人(≥16岁)患者。与第一个十年相比,最后十年患者更老(60.0岁[18.2岁] vs. 62.0岁[17.8岁])、至少一种主要合并症更多(23.2% vs. 25.2%)、APACHE III评分更高(45.6[28.1] vs. 50.9[24.1])。死亡率最高的五个诊断组为心脏骤停(53.6%)、卒中及颅内出血(34.8%)、蛛网膜下腔出血(21.2%)、肺炎(19.2%)和脓毒症(19%)。风险校正死亡率至2010年下降后趋于平台;心脏骤停风险校正死亡率改善最大(第三 vs. 第一个十年OR 0.82 [0.81-0.83]),肺炎改善最小(OR 0.87 [0.87-0.88]);卒中及颅内出血死亡率持续改善,而心脏骤停死亡率近10年似有上升。作者认为平台原因需进一步调查。

要点

  • 心脏骤停、卒中及颅内出血、蛛网膜下腔出血、肺炎、脓毒症是死亡率最高的五个诊断组,死亡率分别为53.6%、34.8%、21.2%、19.2%、19%。
  • 风险校正死亡率至2010年下降后趋于平台;心脏骤停第三 vs. 第一个十年OR 0.82(0.81-0.83),肺炎OR 0.87(0.87-0.88)。
  • 卒中及颅内出血风险校正死亡率持续改善,而心脏骤停死亡率近10年似有上升。
  • 最后十年患者较第一个十年更老(62.0岁[17.8岁] vs. 60.0岁[18.2岁])、合并症更多(25.2% vs. 23.2%)、APACHE III评分更高(50.9[24.1] vs. 45.6[28.1])。
  • 作者认为风险校正死亡率改善趋于平台的原因需进一步调查。

适用人群与场景

  • 1993年1月至2022年12月澳大利亚和新西兰所有向ANZICS APD贡献数据的ICU中,年龄≥16岁的成人患者。

研究设计与关键结果

  • 研究类型为回顾性队列研究;最终队列纳入209个ICU的2,838,654例患者;无干预。
  • 与第一个十年相比,最后十年患者年龄60.0岁(18.2岁)vs. 62.0岁(17.8岁),至少一种主要合并症23.2% vs. 25.2%,APACHE III评分45.6(28.1)vs. 50.9(24.1)。
  • 死亡率最高的五个诊断组:心脏骤停53.6%、卒中及颅内出血34.8%、蛛网膜下腔出血21.2%、肺炎19.2%、脓毒症19%。
  • 风险校正死亡率至2010年下降后趋于平台;心脏骤停第三 vs. 第一个十年OR 0.82(0.81-0.83),肺炎OR 0.87(0.87-0.88)。
  • 大多数诊断组改善模式相似;卒中及颅内出血死亡率持续改善,而心脏骤停死亡率近10年似有上升。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为过去30年ICU风险校正死亡率显著改善但近期趋于平台,平台原因需进一步调查。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The Australia and New Zealand Intensive Care Society (ANZICS) Adult Patient Database (APD) has been operational for 3 decades. It is important to understand how mortality outcomes have changed across diagnostic groups over time to facilitate the planning of future healthcare resources. We evaluated the trends in risk-adjusted mortality for ICU patients over the last 30 years.

DESIGN: A retrospective cohort study.

SETTING: All ICUs in Australia and New Zealand that contributed data to the ANZICS APD from January 1993 to December 2022.

PATIENTS: Adult patients (≥ 16 yr) admitted to Australian and New Zealand ICUs.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: The final cohort included 2,838,654 patients from 209 ICUs. Compared with the first decade patients admitted during the final decade of the study were older (60.0 yr [18.2 yr] vs. 62.0 yr [17.8 yr]), more often had a least one major comorbidity (23.2% vs. 25.2%), and had higher Acute Physiology and Chronic Health Evaluation III scores (45.6 [28.1] vs. 50.9 [24.1]). The five diagnostic groups with the highest mortality rates were cardiac arrest (53.6%), stroke and intracranial hemorrhage (34.8%), subarachnoid hemorrhage (21.2%), pneumonia (19.2%), and sepsis (19%). Risk-adjusted mortality decreased until 2010 but then plateaued. Cardiac arrest saw the greatest improvement in risk-adjusted mortality between the third vs. first study decades (odds ratio [OR], 0.82 [0.81-0.83]), while pneumonia saw the least (OR, 0.87 [0.87-0.88]). The pattern of improvement for most diagnostic groups were similar; however, mortality from stroke and intracranial hemorrhage continued to improve, whereas mortality from cardiac arrest appears to have increased over the past 10 years.

CONCLUSIONS: There have been substantial improvements in risk-adjusted mortality among ICU patients over the past 30 years; however, this improvement has plateaued recently. The reasons for this plateau warrant further investigation.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Pilowsky JK, Ueno R, McLarty J, et al. Mortality Trends Across Key Diagnostic Groups in Australian and New Zealand ICUs Over the Past 30 Years. Crit Care Med. 2025. PMID: 40810586. doi:10.1097/CCM.0000000000006817

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。